Interestingly, inhibition of β-catenin/TCF interaction or blocking WNT ligand secretion prevents the activation of myofibroblasts, suggesting that this mechanism could be druggable to preclude kidney fibrosis and CKD progression. This evidence concerns the gene HNF4A and chronic kidney disease.